Northern Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $632M | Sell |
2,158,025
-73,403
| -3% | -$24.1M | 0.08% | 220 |
|
|
2025
Q4 | $782M | Sell |
2,231,428
-46,221
| -2% | -$15.6M | 0.1% | 170 |
|
|
2025
Q3 | $736M | Sell |
2,277,649
-49,779
| -2% | -$15.5M | 0.09% | 190 |
|
|
2025
Q2 | $905M | Sell |
2,327,428
-114,929
| -5% | -$46.2M | 0.12% | 149 |
|
|
2025
Q1 | $1.06B | Sell |
2,442,357
-6,671
| -0.3% | -$2.68M | 0.16% | 119 |
|
|
2024
Q4 | $903M | Buy |
2,449,028
+346,557
| +16% | +$145M | 0.13% | 138 |
|
|
2024
Q3 | $1.09B | Sell |
2,102,471
-135,192
| -6% | -$72.2M | 0.18% | 107 |
|
|
2024
Q2 | $1.21B | Buy |
2,237,663
+26,282
| +1% | +$13.9M | 0.2% | 87 |
|
|
2024
Q1 | $1.15B | Sell |
2,211,381
-114,177
| -5% | -$56.8M | 0.2% | 94 |
|
|
2023
Q4 | $1.1B | Sell |
2,325,558
-90,901
| -4% | -$42M | 0.2% | 99 |
|
|
2023
Q3 | $1.05B | Buy |
2,416,459
+57,098
| +2% | +$25.9M | 0.2% | 94 |
|
|
2023
Q2 | $1.05B | Sell |
2,359,361
-64,711
| -3% | -$29.9M | 0.2% | 96 |
|
|
2023
Q1 | $1.11B | Sell |
2,424,072
-5,781
| -0.2% | -$2.75M | 0.22% | 87 |
|
|
2022
Q4 | $1.25B | Sell |
2,429,853
-9,137
| -0.4% | -$4.64M | 0.26% | 78 |
|
|
2022
Q3 | $1.11B | Sell |
2,438,990
-18,878
| -0.8% | -$9.03M | 0.25% | 75 |
|
|
2022
Q2 | $1.19B | Buy |
2,457,868
+38,488
| +2% | +$19M | 0.25% | 74 |
|
|
2022
Q1 | $1.19B | Sell |
2,419,380
-45,969
| -2% | -$21M | 0.21% | 91 |
|
|
2021
Q4 | $1.14B | Sell |
2,465,349
-85,340
| -3% | -$35.9M | 0.19% | 101 |
|
|
2021
Q3 | $951M | Sell |
2,550,689
-34,450
| -1% | -$13.1M | 0.17% | 114 |
|
|
2021
Q2 | $987M | Sell |
2,585,139
-100,302
| -4% | -$38.3M | 0.17% | 109 |
|
|
2021
Q1 | $964M | Sell |
2,685,441
-156,349
| -6% | -$50.3M | 0.18% | 111 |
|
|
2020
Q4 | $912M | Sell |
2,841,790
-103,289
| -4% | -$31.7M | 0.18% | 109 |
|
|
2020
Q3 | $791M | Sell |
2,945,079
-6,530
| -0.2% | -$1.76M | 0.17% | 109 |
|
|
2020
Q2 | $776M | Sell |
2,951,609
-10,851
| -0.4% | -$2.89M | 0.18% | 101 |
|
|
2020
Q1 | $673M | Sell |
2,962,460
-19,460
| -0.7% | -$5.3M | 0.19% | 106 |
|
|
2019
Q4 | $901M | Sell |
2,981,920
-334,864
| -10% | -$92.1M | 0.2% | 93 |
|
|
2019
Q3 | $796M | Buy |
3,316,784
+147,053
| +5% | +$40.3M | 0.19% | 103 |
|
|
2019
Q2 | $895M | Buy |
3,169,731
+47,621
| +2% | +$13M | 0.21% | 91 |
|
|
2019
Q1 | $896M | Buy |
3,122,110
+57,447
| +2% | +$16.6M | 0.22% | 87 |
|
|
2018
Q4 | $805M | Buy |
3,064,663
+80,758
| +3% | +$22.2M | 0.23% | 91 |
|
|
2018
Q3 | $818M | Sell |
2,983,905
-39,730
| -1% | -$10.3M | 0.2% | 95 |
|
|
2018
Q2 | $720M | Sell |
3,023,635
-126,529
| -4% | -$29.3M | 0.18% | 104 |
|
|
2018
Q1 | $692M | Sell |
3,150,164
-105,377
| -3% | -$24.8M | 0.18% | 114 |
|
|
2017
Q4 | $733M | Sell |
3,255,541
-19,975
| -0.6% | -$4.25M | 0.19% | 110 |
|
|
2017
Q3 | $622M | Buy |
3,275,516
+260,366
| +9% | +$49.6M | 0.16% | 126 |
|
|
2017
Q2 | $567M | Sell |
3,015,150
-3,507
| -0.1% | -$630K | 0.16% | 124 |
|
|
2017
Q1 | $499M | Buy |
3,018,657
+40,006
| +1% | +$6.36M | 0.14% | 133 |
|
|
2016
Q4 | $428M | Sell |
2,978,651
-16,608
| -0.6% | -$2.22M | 0.13% | 146 |
|
|
2016
Q3 | $375M | Buy |
2,995,259
+6,953
| +0.2% | +$898K | 0.12% | 175 |
|
|
2016
Q2 | $392M | Buy |
2,988,306
+13,035
| +0.4% | +$1.78M | 0.13% | 158 |
|
|
2016
Q1 | $414M | Buy |
2,975,271
+40,194
| +1% | +$5.37M | 0.14% | 146 |
|
|
2015
Q4 | $409M | Sell |
2,935,077
-219,951
| -7% | -$30.3M | 0.14% | 148 |
|
|
2015
Q3 | $442M | Sell |
3,155,028
-98,052
| -3% | -$14.7M | 0.15% | 134 |
|
|
2015
Q2 | $534M | Sell |
3,253,080
-71,342
| -2% | -$11.4M | 0.16% | 127 |
|
|
2015
Q1 | $513M | Sell |
3,324,422
-109,729
| -3% | -$15.6M | 0.15% | 124 |
|
|
2014
Q4 | $432M | Sell |
3,434,151
-56,084
| -2% | -$6.93M | 0.13% | 156 |
|
|
2014
Q3 | $418M | Sell |
3,490,235
-121,154
| -3% | -$13.9M | 0.13% | 154 |
|
|
2014
Q2 | $389M | Sell |
3,611,389
-1,551
| -0% | -$160K | 0.12% | 166 |
|
|
2014
Q1 | $360M | Sell |
3,612,940
-227,354
| -6% | -$20.6M | 0.11% | 178 |
|
|
2013
Q4 | $355M | Sell |
3,840,294
-115,053
| -3% | -$10.2M | 0.11% | 169 |
|
|
2013
Q3 | $331M | Sell |
3,955,347
-91,181
| -2% | -$7.81M | 0.12% | 167 |
|
|
2013
Q2 | $331M | Buy |
+4,046,528
| New | +$303M | 0.12% | 163 |
|
Other funds holding ELV
VCM
VPM
Northern Trust's ELV Position: Q1 2026 in Review
Northern Trust reduced its Elevance Health (ELV) stake by 3.3% in Q1 2026, selling an estimated $24.1M and leaving 2,158,025 shares worth $632M. The position accounts for 0.08% of the portfolio, ranked #220.
Northern Trust first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.25B in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Northern Trust held 2,158,025 shares of Elevance Health worth $632M as of Q1 2026.
- Northern Trust sold 73,403 Elevance Health shares in Q1 2026, an estimated $24.1M.
- Elevance Health made up 0.08% of Northern Trust's portfolio in Q1 2026, its #220 holding.
- Northern Trust first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Elevance Health position peaked at $1.25B in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.